Document text
Principal Investigator: DAVID B. WEINER
Organization: WISTAR INSTITUTE
Fiscal Year: 2022
Award: $1,107,120
Funding agency: National Institute of Allergy and Infectious Diseases
Project 2 Summary
There is an urgent need to develop vaccines which induce robust and lasting immunity against current and
emerging pathogenic coronaviruses (CoVs). These vaccines must also be immunogenic in elderly patients as
they are at increased risk of severe coronavirus disease. Many novel CoVs with pandemic potential remain
poised for human transmission, and elderly patients are at increased risk of morbidity and mortality, emphasizing
the need for predesigned next-generation vaccination platforms with robust preclinical data indicating increased
potency and breadth against structurally related CoVs. This team has recently described the design and study
of in vivo self-assembling nanoparticles for generation of more potent and rapid humoral and cellular responses
in both the HIV and influenza models. Here we propose to apply this proof-of-principal immunization design
strategy in the CoV model system. Under this program we will develop and characterize a series of structurally
tuned, genetically adjuvanted, synthetic DNA (synDNA)-launched nanoparticle (DLNP) immunogens based on
our recent designs for the SARS-CoV-2 spike antigen. We previously reported on the ability of DLNPs to induce
robust immunity compared to traditional synDNA and protein-in-adjuvant vaccine formulations. In collaboration
with Project 1 we will evaluate the capacity of these immunogens to foster potent and durable immunity against
SARS-CoV-2 and related viruses. In summary, the goal of this project is to define the effect of manipulating
epitope valency, size, and adjuvant environment on self-assembling DLNP vaccine on the magnitude,
functionality, and half-life of responses in young and aged mouse models. These experiments will provide
mechanistic insight into the effects of epitope manipulation on vaccine-induced responses and define the
parameters which induce robust and durable anti-CoV immunity.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><ACE2><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Acute><Adenosine Aminohydrolase><Adjuvant><Aging><Animal Model><Animal Models and Related Studies><Animals><Antibodies><Antibody Affinity><Antibody Response><Antigenic Determinants><Antigens><Assay><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><Binding Determinants><Bioassay><Biologic Assays><Biologic Models><Biological Assay><Biological Models><Blood Plasma Cell><CCL27><CCL27 gene><COVID-19 virus><COVID19 virus><CTACK><CTAK><Cell Body><Cell Mediated Immunology><Cell-Mediated Immunity><Cells><Cellular Immunity><Clinic><CoV emergence><CoV-2><CoV2><Collaborations><Coronaviridae><Coronavirus><DNA><DNA delivery><Data><Deoxyribonucleic Acid><Development><Dose><ESKINE><Edodekin Alfa><Environment><Epitopes><Event><Flow Cytofluorometries><Flow Cytofluorometry><Flow Cytometry><Flow Microfluorimetry><Flow Microfluorometry><Formulation><Fostering><Frequencies><Generations><Genetic><Germinal Center><Goals><Grippe><HIV><Half-Life><Human><Human Immunodeficiency Viruses><IL-12><IL12><IgA><Immune><Immunes><Immunity><Immunization><Immunoactivators><Immunoadjuvants><Immunoglobulin A><Immunologic Adjuvants><Immunologic Sensitization><Immunologic Stimulation><Immunological Adjuvant><Immunological Sensitization><Immunological Stimulation><Immunopotentiators><Immunostimulants><Immunostimulation><Infection><Influenza><Interleukin-12><LAV-HTLV-III><Label><Laboratories><Length of Life><Longevity><Lymph Node Reticuloendothelial System><Lymph node proper><Lymphadenopathy-Associated Virus><Lymphatic nodes><MERS><MERS coronavirus disease><MERS-CoV disease><Measures><Mediating><Memory><Memory B Cell><Memory B-Lymphocyte><Mice><Mice Mammals><Middle East Respiratory Syndrome><Middle East Respiratory Syndrome CoV disease><Middle East Respiratory Syndrome coronavirus disease><Middle Eastern Respiratory Syndrome><Middle Eastern Respiratory Syndrome CoV disease><Middle Eastern Respiratory Syndrome coronavirus disease><Model System><Modeling><Modern Man><Morbidity><Morbidity - disease rate><Mucosa><Mucosal Tissue><Mucous Membrane><Murine><Mus><NKSF><Natural Killer Cell Stimulatory Factor><Nucleic Acids><Particle Size><Pathogenicity><Phenotype><Physiologic pulse><Plasma Cells><Plasmacytes><Play><Population><Production><Protocol><Protocols documentation><Public Health><Pulse><Reporting><Risk><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><SCYA27><Selection Criteria><Series><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Site><Structure of germinal center of lymph node><Surface><System><T cell response><T memory cell><T-Cells><T-Lymphocyte><Teff cell><Translations><Transmission><Vaccination><Vaccines><Viral><Virus><Virus-HIV><Work><Wuhan coronavirus><adenosine deaminase><aged><aged population><aging population><angiotensin converting enzyme 2><angiotensin converting enzyme II><antigen antibody affinity><antigen-specific T cells><base><corona virus><corona virus emergence><coronavirus disease 2019 virus><coronavirus disease-19 virus><coronavirus emergence><coronavirus of pandemic concern><coronavirus of pandemic potential><coronavirus vaccine><coronavirus with pandemic potential><cross reactivity><cytokine><cytotoxic CD8 T cells><cytotoxic CD8 T lymphocyte><deliver DNA><design><designing><develop a vaccine><develop vaccines><development of a vaccine><developmental><effector T cell><elderly patient><emergent CoV><emergent corona virus><emergent coronavirus><emerging CoV><emerging corona virus><emerging coronavirus><experiment><experimental research><experimental study><flow cytophotometry><hCoV19><immune adjuvant><immunogen><immunogenic><immunogenicity><improved><in vivo><insight><life span><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><lifespan><lymph gland><lymph nodes><lymphnodes><memory T lymphocyte><model of animal><model organism><mortality><mouse model><murine model><nCoV><nCoV2><nano particle><nano particle delivery><nano-sized particle><nanoparticle><nanoparticle delivered><nanoparticle delivery><nanosized particle><neutralizing antibody><new CoV><new corona virus><new coronavirus><next generation><novel><novel CoV><novel corona virus><novel coronavirus><older patient><pan CoV vaccine><pan coronavirus vaccine><panCoV vaccine><pancoronavirus vaccine><pandemic coronavirus><pandemic threat coronavirus><plasmocyte><population aging><pre-clinical><preclinical><programs><response><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><social role><synthetic DNA><synthetic construct><synthetic protein><thymus derived lymphocyte><transmission process><universal CoV vaccine><universal coronavirus vaccine><vaccine against coronavirus><vaccine development><vaccine formulation><vaccine platform><vaccine response><vaccine responsiveness><vaccine-induced response><vaccinology>